GlassScriptPhysician profile
Dhruv Sethi
NPI 1609440353
$3,706.20
in general payments reported to CMS, 2019-2025
10 companies · $2,127 in 2025
The $2,127 reported for 2025 was more than what 89% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $381 · 2024: $1,199 · 2025: $2,127.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,297 · Travel and Lodging: $409.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,297.20 |
| Travel and Lodging | $409.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,025.84 | 2023-2025 | Unity, Centurion, Clareon |
| Regeneron Healthcare Solutions, INC. | $548.86 | 2024-2025 | Eylea Hd, Eylea |
| Apellis Pharmaceuticals, INC. | $310.80 | 2023-2025 | Syfovre |
| Astellas Pharma Global Development | $158.93 | 2025 | Izervay |
| Abbvie INC. | $154.88 | 2024-2025 | |
| Genentech, INC. | $147.42 | 2025 | Vabysmo |
| Astellas Pharma US INC | $137.21 | 2024 | Izervay |
| Sight Sciences, INC. | $105.51 | 2024-2025 | Omni Surgical System, Sion Surgical Instrument |
| Johnson & Johnson Surgical Vision, INC. | $97.96 | 2024 | Idesign Rs, Star S4 Ir, Wavescan Wavefront System |
| Ani Pharmaceuticals, INC. | $18.79 | 2025 | Iluvien |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dhruv Sethi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.